CN106138185A - 增强肺活力的外用中药组合物、其制备方法及使用方法 - Google Patents
增强肺活力的外用中药组合物、其制备方法及使用方法 Download PDFInfo
- Publication number
- CN106138185A CN106138185A CN201610712585.9A CN201610712585A CN106138185A CN 106138185 A CN106138185 A CN 106138185A CN 201610712585 A CN201610712585 A CN 201610712585A CN 106138185 A CN106138185 A CN 106138185A
- Authority
- CN
- China
- Prior art keywords
- medicine composition
- lung
- raw material
- material components
- external medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 108
- 210000004072 lung Anatomy 0.000 title claims abstract description 92
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 10
- 239000002994 raw material Substances 0.000 claims abstract description 28
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 20
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 18
- 229940025250 camphora Drugs 0.000 claims abstract description 17
- 239000010238 camphora Substances 0.000 claims abstract description 17
- 229940079593 drug Drugs 0.000 claims abstract description 17
- 238000005728 strengthening Methods 0.000 claims abstract description 13
- 238000010298 pulverizing process Methods 0.000 claims abstract description 7
- 229920000742 Cotton Polymers 0.000 claims abstract description 5
- 238000005096 rolling process Methods 0.000 claims abstract description 5
- 210000001364 upper extremity Anatomy 0.000 claims abstract description 5
- 230000005012 migration Effects 0.000 claims abstract description 4
- 238000013508 migration Methods 0.000 claims abstract description 4
- 230000000968 intestinal effect Effects 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims 4
- 210000002429 large intestine Anatomy 0.000 abstract description 10
- 230000000694 effects Effects 0.000 description 26
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 13
- 230000036541 health Effects 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 8
- 230000000474 nursing effect Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000001754 anti-pyretic effect Effects 0.000 description 4
- 239000002221 antipyretic Substances 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010008479 Chest Pain Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010021079 Hypopnoea Diseases 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000001662 opsonic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000008786 sensory perception of smell Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000008359 toxicosis Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000907904 Dipterocarpus Species 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241001083514 Gayophytum Species 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010022714 Intestinal ulcer Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 235000019558 anosmia Nutrition 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- -1 antiinflammatory Substances 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940069016 go-dry Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000004088 pulmonary circulation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种增强肺活力的外用中药组合物,由下述重量百分比的原料组分制成:艾绒40~50%、茵陈32~43%、柴胡8~12%、檀香1~2%、樟脑0~2%、甘草0~1%、冰片0~1%,上述各原料组分含量百分数之和为100%。制备时,分别将上述重量百分比的各原料组分进行粉碎;再将粉碎后的各原料组分混合均匀,从而制备出上述外用中药组合物;再将适量的上述外用中药组合物用棉布进行包装,制作成药拓;使用时,先对药拓进行加热,加热温度在100~120℃,激活中药组合物各组分的药性;再使药拓冷却至45~55℃,制作成温热药拓;再将温热药拓置于人体的背部督脉、膀胱经,上肢肺经、大肠经,并进行扣滚、按摩和游走。
Description
技术领域
本发明涉及一种外用中药组合物,具体地说,本发明涉及一种增强肺活力的外用中药组合物;同时,本发明还涉及上述外用中药组合物的制备方法以及上述外用中药组合物的使用方法。
背景技术
自古以来,采用中药施于皮肤,治疗身体各种疾病,这已成为中华医学的一朵奇葩,许多医学文献中均有记载,清代的《理论骈文》就有很好的描述,中医药的讲究也在于内服外敷原理,在应对身体出现不适的各个方面都起着不同凡响的作用。人体在日常生活中所吸收的有害物质,若没有得到及时排泄,它会沉淀于血液中,当血液流动出现涩滞时,引起睡眼不足、腰酸背痛、浑身泛力等症状。
例如:肺主诸气,司呼吸,吸入清气与脾运化的水谷精微结合,化为元气,维持生命。肺朝百脉,气推动血运行,有赖于肺。肺参与人体水液代谢,通调水道。肺开窍于鼻,主皮毛,凡皮肤、鼻、咽喉诸症,皆与肺有关。肺和心同为上焦,相互依存。肺主气,心主血,气离血死,血离气枯。肺与大肠相表里。
肺正常与否的表象:
1、肺气足,精力旺盛。
肺气足,人的血液中含氧充足,必然精力旺盛。老年人生病时往往气短,因肺气弱而身体缺氧,必然导致精疲力竭。
2、肺气足,皮肤光滑。
“肺主皮毛”。肺气足,皮肤层气血充足,营养物质丰富,皮肤柔嫩、光滑,毛孔细;肺气虚,皮肤抵抗力弱,皮肤容易出现皮下红疹、皮癣,面有红斑、粉刺,面部毛孔粗,皮肤过敏。
3、肺气足,鼻子精巧。
“肺开窍于鼻”。肺气足,鼻子光亮、精巧;肺气虚,鼻子毛孔渐粗,或鼻翼变红,重则为“酒糟鼻”。
4、肺气足,人不虚胖。
“肺通调水道,下输膀胱”。肺调节人体的水分,需要与脾、肾相互配合,缺一不可,任何一个环节出了毛病,都会引起体内水液代谢不利,形成虚胖,重则浮肿。
5、肺气足,不易感冒。
“肺主卫气”。肺气足,可形成保卫身体之气,预防病邪从气管和皮肤侵入,使人不轻易感冒。
6、肺气足,嗅觉灵敏。
肺气足,鼻内不生炎症,嗅觉灵敏;肺气虚,易患鼻炎,容易过敏,有时不辨香臭。
7、肺气足,人不忧愁。
“肺主忧”。肺气足,人常欢喜;肺气虚,人多忧愁。
肺虚有肺阴虚、肺阳虚之分,不同症状如下:
1、肺阴虚。
肺阴,是肺循环系统的物质基础部分。肺阴虚相当于肺的物质基础薄弱,肺自身的阴液不足,细胞在运动中摩擦力过大,出现燥热。肺阴虚时干咳少痰,潮热盗汗,两颧潮红,手足心热,咽燥音哑,舌红干燥,苔少。肺与大肠相表里,肺阴虚可引起肠燥,导致便秘。
2、肺阳虚。
肺阳虚时咳喘无力,流清鼻涕,痰多清稀,甚则喘促或呼吸困难,疲倦,懒语,声低,怕冷,自汗,脸色青白,舌胖淡嫩。
综上所述,肺虚的症状主要病因是肺的阴阳失衡,肺活力不够,因此,治疗肺虚症状的主要方法是增强肺活力,使肺气足,以保持肺的阴阳平衡。
发明内容
本发明所要解决的第一个技术问题是:提供一种增强肺活力的外用中药组合物,以使肺气足,保持肺的阴阳平衡。
为了解决上述第一个技术问题,本发明采用的技术方案如下:
一种增强肺活力的外用中药组合物,其特征在于:由下述重量百分比的原料组分制成:艾绒40~50%、茵陈32~43%、柴胡8~12%、檀香1~2%、樟脑0~2%、甘草0~1%、冰片0~1%,上述各原料组分含量百分数之和为100%。
作为本发明的第一种优选技术方案:
所述各原料组分的重量百分比为:艾绒45%、茵陈41%、柴胡9%、檀香1.5%、樟脑1.5%、甘草1%、冰片1%。
作为本发明的第二种优选技术方案:
所述各原料组分的重量百分比为:艾绒50%、茵陈33.5%、柴胡11.5%、檀香1.5%、樟脑2%、甘草0.5%、冰片1%。
作为本发明的第三种优选技术方案:
所述各原料组分的重量百分比为:艾绒41%、茵陈43%、柴胡12%、檀香2%、樟脑1%、甘草0.5%、冰片0.5%。
上述各原料组分的药性和功效如下:
艾绒:是艾草的天然加工品,归脾胃,肝胆经。它的功效主要有:通经活络、温经止血,散寒止痛、保肝利胆、清热、利湿退黄、生肌安胎、回阳救逆、养生保健、具有较强抗病原微生物的作用。外用灸法则能灸治百病。
茵陈:别名牛至、田耐里、因尘、马先、绵茵陈、绒蒿、白蒿、细叶青蒿、安吕草。归脾、胃、肝、胆经。全草入药,可预防流感,治中暑、感冒、头痛身重、腹痛、呕吐、胸膈胀满、气阻食滞、小儿食积腹胀、腹泻、月经过多、崩漏带下、皮肤搔痒及水肿等症,其散热发表功用,尤胜于薄荷。清热利湿;退黄。主治:黄疸、小便不利、湿疮瘙痒、传染性黄疸型肝炎等药理学研究有利胆,保护肝功能解热,抗炎,降血脂,扩冠等作用,茵陈有显著的保肝作用,对甲、乙型肝炎,黄疸型肝炎,有显著的疗效。有利胆,促进胆汁分泌,增加胆汁中胆酸和胆红素排出的作用。能增加心脏冠脉血流量,改善微循环,并有降血压,降血脂,抗凝血,利尿解热平喘,驱除蛔虫及抑制多种致病性皮肤真菌与细菌的作用。
柴胡:别名地熏、山菜、菇草、柴草,性味苦、微寒。归肝、胆经。有和解表里,疏肝升阳举陷,退热截疟之功效。用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱垂、月经不调。
檀香:又名白檀,归脾、胃、心、肺经;行心温中,开胃止痛。外敷可以消炎去肿,滋润肌肤;熏烧可杀菌消毒,驱瘟辟疫。能治疗喉咙痛、粉刺、抗感染、抗气喘。有调理敏感肤质,防止肌肤老化的功效。去邪、去燥、杀菌、防霉、防虫、防蛀。具有安抚神经,辅助冥思、提神静心之功效。从檀香中提取的檀香油在医药上也有广泛的用途,具有清凉、收敛、强心、滋补、润滑皮肤等多重功效,可用来治疗胆汁病,膀胱炎、淋病以及腹痛、发热、呕吐等病症,对龟裂、富贵手、黑斑、蚊虫咬伤等症特别有效,古来就是对治皮肤病的重要药品。檀香不仅拥有良好的理疗特性和宜人的香气,同时也因其特殊的成分特性,而成为非常有效的定香剂和防腐剂。檀香在皮肤护理上是很好的男性及女性护肤保养品,特别是针对干燥缺水性的肌肤保养,此外它也常用在男性剃须膏、剃须水的制作上。檀香精油对生殖泌尿系统有特别好的功效,对泌尿系统的感染病症具有非常好的消毒杀菌功能,同时对肺部的病症亦有显著功效。
樟脑:别名,韶脑(《神效方》),潮脑(《品汇精要》),脑子(《本经逢原》),油脑、树脑(《药材资料汇编》)。《本草再新》:“入心、脾二经”。具有通关窍、利滞气、辟秽浊、杀虫止痒、消肿止痛的功效,主治疥癣瘙痒、跌打伤痛、牙痛等症状。涂于皮肤有温和的刺激及防腐作用。用力涂擦有发赤作用;轻涂则类似薄荷,有清凉感,此乃由于刺激冷觉感受器的作用。它还有轻度的局部麻醉作用。对于胃肠道粘膜,樟脑有刺激作用,使胃部感到温暖及舒适,大量则能产生恶心及呕吐。临床上用樟脑擦剂有镇痛、止痒作用。口服有驱风作用以及轻微的祛痰作用。
甘草:别名:国老、甜草、乌拉尔甘草、甜根子。归心、肺、脾、胃经 。豆科、甘草属多年生草本,根与根状茎粗壮,是一种补益中草药。对人体很好的一种药,药用部位是根及根茎,气微,味甜而特殊。补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。清热解毒,润肺止咳,调和诸药;炙甘草能补脾益气。主治咽喉肿痛,咳嗽,脾胃虚弱,胃、十二指肠溃疡,肝炎,癔病,痈疖肿毒,药物及食物中毒。和中缓急,润肺,解毒,调和诸药。炙用,治脾胃虚弱,食少,腹痛便溏,劳倦发热,肺痿咳嗽,心悸,惊痫;生用,治咽喉肿痛,消化性溃疡,痈疽疮疡,解药毒及食物中毒。益气补中;缓急止痛;润肺止咳;泻火解毒;调和诸药。主倦怠食少;肌瘦面黄;心悸气短;腹痛便溏;四肢挛急疼痛;脏躁;咳嗽气喘;咽喉肿痛;痈疮肿痛;小儿胎毒;有类似肾上腺皮质激素样作用。对组胺引起的胃酸分泌过多有抑制作用;并有抗酸和缓解胃肠平滑肌痉挛作用。甘草还有抗炎,抗过敏作用,能保护发炎的咽喉和气管粘膜。常用来治疗随更年期而来的症状。因为甘草里含有甘草素,是一种类似激素的化合物,它有助于平衡女性体内的激素含量。所含的次酸能阻断致癌物诱发肿瘤生长的作用。
冰片:又名片脑、桔片、艾片、龙脑香、梅花冰片、羯布罗香、梅花脑、冰片脑、梅冰等,冰片味辛、苦,微寒;归心、肝、肺经;清香宣散,具有开窍醒神,清热散毒,明目退翳的功效,主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮睛 。通诸窍,散郁火,去翳明目,消肿止痛,散火解毒。治乳腺结块,中风口噤,热病神昏,惊痫痰迷,气闭耳聋,喉痹,口疮,中耳炎,痈肿,痔疮,目亦翳膜,蛲虫病。
本发明所要解决的第二个技术问题是:提供一种上述外用中药组合物的制备方法。
为了解决上述第二个技术问题,本发明采用的技术方案如下:
一种上述外用中药组合物的制备方法,其特征在于:
分别将上述重量百分比的各原料组分进行粉碎;再将粉碎后的各原料组分混合均匀,从而制备出上述外用中药组合物。
本发明所要解决的第三个技术问题是:提供一种上述外用中药组合物的使用方法。
为了解决上述第三个技术问题,本发明采用的技术方案如下:
一种上述外用中药组合物的使用方法,其特征在于:将适量的上述外用中药组合物用棉布进行包装,从而制作成药拓;使用时,首先,对药拓进行加热,加热温度在100~120℃,从而激活中药组合物各组分的药性;接着,使药拓冷却至45~55℃,从而制作成温热药拓;然后,将温热药拓置于人体的背部督脉、膀胱经,上肢肺经、大肠经,并进行扣滚、按摩和游走。
这样,上述外用中药组合物的有效成分便通过毛细血管加入体内微循环,从而使外用中药组合物的有效成分得以充分吸收。
每星期进行一次,对肺、大肠有保健与调理作用。
本发明对照现有技术的有益效果是:
本外用中药组合物采用一定重量百分比的艾绒、茵陈、柴胡、檀香、樟脑、甘草和冰片等原料组分,并分别将上述各原料组分进行粉碎;再将粉碎后的各原料组分混合均匀,从而制备出一种增强肺活力的外用中药组合物;再将适量的上述外用中药组合物用棉布进行包装,从而制作成药拓;使用时,首先,对药拓进行加热,加热温度在100~120℃,从而激活中药组合物各组分的药性;接着,使药拓冷却至45~55℃,从而制作成温热药拓;然后,将温热药拓置于人体的背部督脉、膀胱经,上肢肺经、大肠经,并进行扣滚、按摩和游走;这样,上述外用中药组合物的有效成分便通过毛细血管加入体内微循环,从而使外用中药组合物的有效成分得以充分吸收;
因此,本外用中药组合物主要是根据中医药学、药理,利用艾绒的散寒止痛、抗病原微生物和茵陈的解热、抗炎、利尿、平喘等功效;辅以和解表里的柴胡和具祛邪、祛燥、杀菌、消炎祛肿的檀香;加以通关窍、利滞气的樟脑,润肺、解毒的甘草和开窍清神、清热解毒的冰片等原料组分;并将上述各原料组分粉碎、混合均匀后制备成药拓,通过加热药拓,使中药组合物各组分的药性激活,再冷却成温热药拓,并将温热药拓施于人体皮肤经络、穴位之上,利用人体五行经络相对应的督脉、膀胱经、肺经、大肠经,经按摩、推拿,打通身体经络,使身体气血通畅,从而改善肺气、增强肺活力,进而保持肺的阴阳平衡,保持身体处于健康水平。
同时,本外用中药组合物还具有使用方便、功效好、安全无副作用等优点。
本外用中药组合物特别适用于改善因生活环境因素引起的呼吸不畅、胸痛、咳嗽、气短、易感疲劳等症状。
具体实施方式
优选实施例1
本优选实施例中的增强肺活力的外用中药组合物,由下述重量百分比的原料组分制成:艾绒45%、茵陈41%、柴胡9%、檀香1.5%、樟脑1.5%、甘草1%、冰片1%。
优选实施例2
本优选实施例中的增强肺活力的外用中药组合物,由下述重量百分比的原料组分制成:艾绒50%、茵陈33.5%、柴胡11.5%、檀香1.5%、樟脑2%、甘草0.5%、冰片1%。
优选实施例3
本优选实施例中的增强肺活力的外用中药组合物,由下述重量百分比的原料组分制成:艾绒41%、茵陈43%、柴胡12%、檀香2%、樟脑1%、甘草0.5%、冰片0.5%。
制作上述优选实施例中的增强肺活力的外用中药组合物时,分别将优选实施例中的重量百分比的各原料组分进行粉碎,过筛200目;再将粉碎后的各原料组分混合均匀,从而制备出增强肺活力的外用中药组合物。
使用上述优选实施例中的增强肺活力的外用中药组合物时,将适量的上述外用中药组合物用棉布进行包装,从而制作成药拓;使用时,首先,对药拓进行加热,加热温度在100~120℃,从而激活中药组合物各组分的药性;接着,使药拓冷却至45~55℃,从而制作成温热药拓;然后,将温热药拓置于人体的背部督脉、膀胱经,上肢肺经、大肠经,并进行扣滚、按摩和游走。这样,上述外用中药组合物的有效成分便通过毛细血管加入体内微循环,从而使外用中药组合物的有效成分得以充分吸收。
因此,本外用中药组合物主要是根据中医药学、药理,利用艾绒的散寒止痛、抗病原微生物和茵陈的解热、抗炎、利尿、平喘等功效;辅以和解表里的柴胡和具祛邪、祛燥、杀菌、消炎祛肿的檀香;加以通关窍、利滞气的樟脑,润肺、解毒的甘草和开窍清神、清热解毒的冰片等原料组分;并将上述各原料组分粉碎、混合均匀后制备成药拓,通过加热药拓,使中药组合物各组分的药性激活,再冷却成温热药拓,并将温热药拓施于人体皮肤经络、穴位之上,利用人体五行经络相对应的督脉、膀胱经、肺经、大肠经,经按摩、推拿,打通身体经络,使身体气血通畅,从而改善肺气、增强肺活力,进而保持肺的阴阳平衡,保持身体处于健康水平。
每星期进行一次,对肺、大肠有保健与调理作用。
临床试验:
王姐:40岁。
食欲不振、体重下降,呼吸不畅、胸痛、易患感冒等。
经专家诊断:王姐属明显肺虚症状。建议使用本外用中药组合物药拓,辅以穴位按摩护理,增加肠道保养护理,排出体内瘀滞。经护理至第3周,王姐胃口 开始好转,体重略有上升。第5周胸部有轻松无压迫感,胸痛有所缓解,感冒次数明显减少。
黄先生:42岁。
脸色暗黄、体型偏胖、脸部肌肉松驰,有喜烟、酒习惯、伴有咳嗽、胡须早白。
经专家罐诊:黄先生因生意应酬多,饮食及节息时间不准时等引起严重肺部虚症。建议使用本外用中药组合物药拓,辅以调养肝的外用中药组合物药拓及穴位按摩护理,先补充肺部阳气、肝部排毒。至第5周,面部开始红润有光。通过护理及减烟,酒第8周脸部皮肤紧致,咳嗽也明显改善。
纪姐:35岁。
脸色憔悴、头发干枯、皮肤干燥、气短、易感疲劳。
经专家罐诊:纪姐属家庭主妇经常吸入厨房油烟,致有轻微气管炎、肺气肿等症状。
建议使用本外用中药组合物药拓,辅以肠道疏通护理及穴位按摩护理。至第4周呼吸开始平缓有力,精神状态有所好转。第7周脸色开始红润,干枯头发渐有光泽、弹性。
上述具体实施方式的内容只是本发明的优选实施例,上述优选实施例并非用来限定本发明的实施范围,因此,凡是依照本发明其权利要求的保护范围所做出的各种各样的等同变换,均被本发明其权利要求的保护范围所覆盖。
Claims (6)
1.一种增强肺活力的外用中药组合物,其特征在于:由下述重量百分比的原料组分制成:艾绒40~50%、茵陈32~43%、柴胡8~12%、檀香1~2%、樟脑0~2%、甘草0~1%、冰片0~1%,上述各原料组分含量百分数之和为100%。
2.根据权利要求1所述的增强肺活力的外用中药组合物,其特征在于:所述各原料组分的重量百分比为:艾绒45%、茵陈41%、柴胡9%、檀香1.5%、樟脑1.5%、甘草1%、冰片1%。
3.根据权利要求1所述的增强肺活力的外用中药组合物,其特征在于:所述各原料组分的重量百分比为:艾绒50%、茵陈33.5%、柴胡11.5%、檀香1.5%、樟脑2%、甘草0.5%、冰片1%。
4.根据权利要求1所述的增强肺活力的外用中药组合物,其特征在于:所述各原料组分的重量百分比为:艾绒41%、茵陈43%、柴胡12%、檀香2%、樟脑1%、甘草0.5%、冰片0.5%。
5.根据权利要求1或2或3或4所述的增强肺活力的外用中药组合物的制备方法,其特征在于:分别将上述重量百分比的各原料组分进行粉碎;再将粉碎后的各原料组分混合均匀,从而制备出上述外用中药组合物。
6.根据权利要求5所述的增强肺活力的外用中药组合物的使用方法,其特征在于:将适量的上述外用中药组合物用棉布进行包装,从而制作成药拓;使用时,首先,对药拓进行加热,加热温度在100~120℃,从而激活中药组合物各组分的药性;接着,使药拓冷却至45~55℃,从而制作成温热药拓;然后,将温热药拓置于人体的背部督脉、膀胱经,上肢肺经、大肠经,并进行扣滚、按摩和游走。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610712585.9A CN106138185A (zh) | 2016-08-24 | 2016-08-24 | 增强肺活力的外用中药组合物、其制备方法及使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610712585.9A CN106138185A (zh) | 2016-08-24 | 2016-08-24 | 增强肺活力的外用中药组合物、其制备方法及使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106138185A true CN106138185A (zh) | 2016-11-23 |
Family
ID=57343163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610712585.9A Pending CN106138185A (zh) | 2016-08-24 | 2016-08-24 | 增强肺活力的外用中药组合物、其制备方法及使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106138185A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1325720A (zh) * | 2001-04-26 | 2001-12-12 | 张莉 | 一种治疗结核病的药物组合物及其制备方法 |
CN1823965A (zh) * | 2005-12-19 | 2006-08-30 | 刘铭发 | 治疗新生儿肺炎的外用药 |
CN102198307A (zh) * | 2010-03-22 | 2011-09-28 | 北京泰颐堂科技发展有限公司 | 外用拓 |
-
2016
- 2016-08-24 CN CN201610712585.9A patent/CN106138185A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1325720A (zh) * | 2001-04-26 | 2001-12-12 | 张莉 | 一种治疗结核病的药物组合物及其制备方法 |
CN1823965A (zh) * | 2005-12-19 | 2006-08-30 | 刘铭发 | 治疗新生儿肺炎的外用药 |
CN102198307A (zh) * | 2010-03-22 | 2011-09-28 | 北京泰颐堂科技发展有限公司 | 外用拓 |
Non-Patent Citations (1)
Title |
---|
国医编委会: "固表温肺饮", 《食物速效小偏方》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107308097A (zh) | 一种化妆组成物 | |
CN102670784B (zh) | 一种治疗鼻炎、鼻窦炎的中药制剂 | |
CN107789521A (zh) | 一种缓解眼疲劳、治疗近视的复方中药组合物眼贴 | |
CN107693741A (zh) | 一种开郁消积香囊及其制备方法 | |
CN109674912A (zh) | 一种调理痰湿体质的中药泡浴抑菌液/颗粒及制备与使用方法 | |
CN105796943A (zh) | 足浴药袋 | |
CN109674704A (zh) | 一种调理湿热体质的中药泡浴抑菌液/颗粒及制备与使用方法 | |
CN107744563A (zh) | 一种强身健体保健浴粉 | |
CN103989936B (zh) | 一种亚健康调理液及其制备方法 | |
CN106860718A (zh) | 一种足浴粉及其制备方法 | |
CN105994747A (zh) | 一种防治口臭的保健茶及其制备方法 | |
CN106138185A (zh) | 增强肺活力的外用中药组合物、其制备方法及使用方法 | |
CN105727163A (zh) | 一种治疗肝癌的中药配方及其制备方法 | |
CN106139102A (zh) | 调养肾的外用中药组合物、其制备方法及使用方法 | |
CN105012732B (zh) | 一种用于治疗睡眠障碍综合征的中药丸剂及制备方法 | |
CN102626503B (zh) | 一种舒心益智的中药口服液 | |
CN106822300A (zh) | 一种祛痘美颜的中药制剂 | |
CN102416157B (zh) | 用中药制备的穴位贴剂及其制备方法 | |
CN107669846A (zh) | 一种定喘膏 | |
CN108403910A (zh) | 一种治疗湿疹的茶药 | |
CN106138475A (zh) | 一种预防糖尿病皮肤病的浴足中药组合物 | |
CN106214871A (zh) | 增强心脏动力的外用中药组合物、其制备方法及使用方法 | |
CN105535461A (zh) | 一种用于防治小儿风热型感冒的中药片剂及制备方法 | |
CN105343647A (zh) | 一种治疗神经衰弱的中药制剂 | |
CN114224999A (zh) | 姜艾粉 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161123 |